Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

TSHA Taysha Gene Therapies Inc

1,54

0,01 (0,65%)

22 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Taysha Gene Therapies Charts.

Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Taysha Gene Therapies Charts.

News Taysha Gene Therapies Inc

Form S-8 - Securities to be offered to employees in employee benefit plans
Dienstag 7 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Freitag 3 Januar 2025 (3 Wochen vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Montag 23 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Freitag 13 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Freitag 6 Dezember 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Mittwoch 13 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 8 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13
Mittwoch 6 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Freitag 1 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress
Dienstag 22 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Freitag 4 Oktober 2024 (4 Monate vor) • GlobeNewswire Inc.

Weitere Taysha Gene Therapies Inc News-Artikel

JP Morgan Chase

Gold vs US Dollar

Health Care Select Sector

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen